DeepCurrents Investment Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

DeepCurrents Investment Group’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,706	Closed	-$44.7K	–	207
2024 Q4	$44.7K	Hold	14,706	–	–	﹤0.01%	160
2024 Q3	$76.3K	Buy	+14,706	New	+$73.1K	﹤0.01%	164

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

DeepCurrents Investment Group's RVNC Position: Q1 2025 in Review

DeepCurrents Investment Group sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 14,706 shares — an estimated $44.7K sold.

DeepCurrents Investment Group first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $76.3K in Q3 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

DeepCurrents Investment Group reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
DeepCurrents Investment Group sold 14,706 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $44.7K.
DeepCurrents Investment Group first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
DeepCurrents Investment Group's Revance Therapeutics, Inc. position peaked at $76.3K in Q3 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on DeepCurrents Investment Group's 13F filing for Q1 2025, filed 15 May 2025.